- Home
- / D.WESTERN THERAPEUTICS INSTITUTE
D.WESTERN THERAPEUTICS INSTITUTE
Stock Price
¥66
2024-10-29
Market Capitalization
¥2.5 B
2024-10-29
Revenue
¥387.6 M
FY, 2025
D.WESTERN THERAPEUTICS INSTITUTE Summary
Company Summary
- Overview
- D.WESTERN THERAPEUTICS INSTITUTE is a biotechnology company that focuses on developing drugs for the healthcare sector. It offers ophthalmic surgical adjuvant for cataract surgeries, ilm staining and peeling, glanatec, multikinase inhibitor, and other solutions.
- Type
- Public
- Status
- Active
- Founded
- 1999
- Website
- http://dwti.co.jp
- Cybersecurity rating
Table of Contents
D.WESTERN THERAPEUTICS INSTITUTE Financials
Summary Financials
- Revenue (FY, 2025)
- ¥387.6M
- Gross profit (FY, 2025)
- ¥348.8M
- Net income (FY, 2025)
- (¥632.1M)
- Cash (FY, 2025)
- ¥1.7B
- EBIT (FY, 2025)
- (¥619.6M)
- Enterprise value
- $1.4B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026